In patients with chronic hepatitis B infection, bepirovirsen achieves significantly higher rates of functional cure than placebo after discontinuation of nucleoside or nucleotide analog therapy.
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...
End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming immune responses for functional cure ...
Hepatitis B (HBV) and hepatitis C (HCV) are viral infections that can lead to health conditions such as cirrhosis, cancer, ...
Please provide your email address to receive an email when new articles are posted on . Global HBV incidence and mortality rates dropped from 1990 to 2021 among individuals aged 15 to 49 years.
Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why ...
In the world of viral hepatitis, Hepatitis B (HBV) and Hepatitis C (HCV) are usually at the centre of attention. Although both are viral infections that primarily affect the liver, causing ...
Ethiopia has made significant progress in expanding antiretroviral therapy, but a new study from Northwest Ethiopia shows why ...
The CDC Advisory Committee on Immunization Practices recently ended the federal recommendation for a universal birth dose of the hepatitis B vaccine. If you’re following this issue, you may also know ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Newborn HBV vaccination rates in the U.S. peaked at 83.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results